Dr. Xuetao Cao is the President of Chinese Academy of Medical Sciences and the President of Peking Union Medical College. He received his M.D. degree in 1986 and a Ph.D degree in Immunology 1990 from the Second Military Medical University in Shanghai, China. He became Professor in Immunology at the Second Military Medical University In 1993 and the Founder Director of the Institute of Immunology at the same University in 2001. In 2000 he became the founding Director of the Institute of Immunology at Zhejiang University and in 2006 also became the Director of the China National Key Laboratory of Medical Immunology. Dr. Cao is an elected member of numerous academic societies, such as the Chinese Academy of Engineering (2005), German Academy of Sciences (2013), French Academy of Medicine (2014), EMBO (2015), UK Academy of Medical Sciences (2016) and US National Academy of Medicine (2017). In the past he has served as the President of Chinese Society for Immunology (2006-2014), President of Federation of Immunological Societies in Asia and Oceania (FISMA, 2012-2015) and as President of Global Alliance for Chronic Diseases (2013-2015). Dr. Cao is currently the Secretary General of Chinese Society for Immunology, Secretary General of FIMSA, and President of China Union of Life Science Societies.
His research focuses on the understanding of molecular and cellular mechanisms in innate immunity and inflammation, cancer immunotherapy. As corresponding author, Dr. Cao has published more than 250 original papers in peer-reviewed journals such as Cell, Nature, Science, Nature Immunology, Cancer Cell, and Immunity. He is Founder and Editor-in-Chief of Chinese Journal of Cancer Biotherapy, Co-Editor-in-Chief of Cellular and Molecular Immunology and Senor Editor of Cancer Immunology Research. He also serves on the editorial board of a number of international journals including Cell, Annual Reviews of Immunology, Science Translational Medicine, eLife, Cell Research. Dr. Cao has won many awards in recognition of his scientific achievements and dedication to public services as well as his contributions to medical research and education, such as Nature Awards in Mentorship for Science (2015)
Methyltransferase SETD2-Mediated Methylation of STAT1 Is Critical for Interferon Antiviral Activity. Cell. 2017;170(3):492-506